| Members |
targetComponentId |
| Clostridium thermosaccarolyticum |
Thermoanaerobacterium thermosaccharolyticum |
| Clostridium thermosaccharolyticum |
Thermoanaerobacterium thermosaccharolyticum |
| Clostridium thermosulfurigenes |
Thermoanaerobacterium thermosulfurigenes |
| Clostridium villosum |
Filifactor villosus |
| Closure by clamp |
Application of clamp (procedure) |
| Closure of artificial opening of small intestine |
Closure of stoma of small intestine |
| Closure of enterovesical fistula |
Repair of fistula involving bladder and intestine |
| Closure of fistula |
Closure - action |
| Closure of ileorectal fistula |
Repair of ileorectal fistula |
| klotrimazol 1 %, ögondroppar |
Clotrimazole only product in ocular dose form |
| klotrimazol 1 %, ögondroppar utan konserveringsmedel |
Clotrimazole only product in ocular dose form |
| klotrimazol 100 mg, vaginaltablett |
Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) |
| Clotrimazole 10mg tablet |
Product containing precisely clotrimazole 10 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
| klotrimazol 2 % + 10 %, kräm + applikator |
Product containing only clotrimazole (medicinal product) |
| Clotrimazole 2%+10% cream+applicator |
Product containing only clotrimazole (medicinal product) |
| klotrimazol 200 mg, suppositorium |
Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) |
| klotrimazol vaginaltablett 200 mg + kräm 1 % |
Product containing only clotrimazole (medicinal product) |
| klotrimazol 500 mg, vaginaltablett |
Clotrimazole 500 mg vaginal tablet |
| klotrimazol vagitorium 500 mg + kräm 2 % |
Product containing only clotrimazole (medicinal product) |
| kloxacillinnatrium 125 mg/5 ml, oral lösning |
Product containing precisely cloxacillin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| övervakning av klozapinbehandling |
Monitoring of clozapine therapy |
| Co, kobolt i kosten |
Cobalt |
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett |
Benserazide 12.5 mg and levodopa 50 mg oral tablet |
| benserazid 25 mg + levodopa 100 mg, dispergerbar tablett |
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
| benserazid 25 mg + levodopa 100 mg, kapsel med modifierad frisättning |
Product containing only benserazide and levodopa (medicinal product) |
| benserazid 25 mg + levodopa 100 mg, depåkapsel |
Product containing only benserazide and levodopa (medicinal product) |
| Co-careldopa 10mg/100mg tablet |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-careldopa 25mg/100mg m/r tablet |
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
| Co-careldopa 25mg/100mg tablet |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet |
| Co-careldopa 25mg/250mg tablet |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-careldopa 50mg/200mg m/r tablet |
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
| paracetamol 500 mg + kodein 8 mg, dispergerbar tablett |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
| Co-codaprin 8mg/500mg dispersible tablet |
Aspirin and codeine only product in oral dose form |
| trimetoprim 160 mg + sulfametoxazol 800 mg, dispergerbar tablett |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
| Co-trimoxazole 16mg/80mg/mL infusion solution 10mL ampule |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
| trimetoprim 80 mg + sulfametoxazol 400 mg, dispergerbar tablett |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
| co-trimoxazol 960 mg/10 ml, infusionsvätska |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
| Coagulation Factor VIIa (cattle) |
Coagulation factor VIIa |
| Coagulation Factor XIIa |
Coagulation factor XIIa |
| Coagulation Factor XIa |
Coagulation factor XIa |
| Coagulation Factor Xa |
Coagulation factor Xa |
| Coagulation factor IV |
Calcium |
| Coagulation factor IXa |
Coagulation factor IXa |
| koltjära 10 %, preparat för pensling |
Coal tar 100 mg/mL cutaneous solution |
| koltjära 30 %, emulsion för bad |
Product containing precisely coal tar 300 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| koltjära 40 %, emulsion för bad |
Product containing precisely coal tar 400 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
| koltjära 40 %, kutan lösning |
Product containing only coal tar in cutaneous dose form (medicinal product form) |
| koltjäreextrakt 2 %, schampo |
Product containing precisely coal tar 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
| salva med koltjära |
Coal tar |
| koltjärelösning för lokalt bruk |
Coal tar |
| kokain, icke läkemedel |
Cocaine (substance) |
| kokain, läkemedel |
Cocaine (substance) |
| kokain 10 %, näsdroppar |
Cocaine 100 mg/mL nasal solution |
| kokain 20 %, ögondroppar |
Cocaine (as cocaine hydrochloride) 200 mg/mL eye solution |
| kokain 4 %, ögondroppar |
Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
| kokain 4 %, ögondroppar utan konserveringsmedel |
Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
| kokain 5 %, ögondroppar |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter conventional release eye solution (clinical drug) |
| kokainhydroklorid, icke läkemedel |
Cocaine hydrochloride |
| kokainhydroklorid 10 %, ögondroppar, lösning |
Product containing only cocaine in ocular dose form (medicinal product form) |
| kokainhydroklorid 10 %, lösning för engångsbruk |
Product containing only cocaine in ocular dose form (medicinal product form) |
| Cocaine hydrochloride 10% topical solution |
Product containing only cocaine (medicinal product) |
| kokainhydroklorid 2,5 %, ögondroppar, lösning |
Product containing only cocaine in ocular dose form (medicinal product form) |
| kokainhydroklorid 2,5 %, lösning för engångsbruk |
Product containing only cocaine in ocular dose form (medicinal product form) |
| Cocaine hydrochloride 4% topical solution |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
| kokain 10 %, viskös kutan lösning |
Product containing only cocaine (medicinal product) |
| kokain 10 %, viskös lösning för lokalt bruk |
Product containing only cocaine (medicinal product) |
| kokain 4 %, viskös kutan lösning |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
| kokain 4 %, viskös lösning för lokalt bruk |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
| kokain 5 % + adrenalin 0,02 %, ögondroppar |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) |
| kokain 2 % + homatropin 2 %, ögondroppar |
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution |
| Cochleo-orbicular reflex |
Auropalpebral reflex finding |
| kokos, livsmedel |
Coconut (substance) |
| torsk, livsmedel |
Cod (substance) |
| kodeinfosfat 10 mg + prometazinhydroklorid 6,25 mg, sirap |
Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
| kodeinfosfat 10 mg/10 ml + kaolin 3 g/10 ml, mixtur |
Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Coelenterate |
Phylum Cnidaria (organism) |
| Coenzyme-A transferase |
Coenzyme-A transferase |
| Coital sexual orgasm |
Coital sexual orgasm |
| kall miljö |
Cold environment |
| kolestyramin + aspartam 4 g, dospåse, oralt pulver |
Product containing only colestyramine (medicinal product) |
| Colestyramine+aspartame 4g/sachet s/f oral powder |
Product containing only colestyramine (medicinal product) |
| kolestyramin + aspartam, dospåse 4 g, sockerfritt pulver för oralt bruk |
Product containing only colestyramine (medicinal product) |
| natriumkolistimetat 1 miljon internationella enheter, pulver för nebulisator |
Colistimethate 40 mg/mL solution for inhalation |
| kolistinsulfat 1,5 miljoner enheter, tablett |
Product containing precisely colistin 1.5 million unit/1 each conventional release oral tablet (clinical drug) |
| kolitoxemi |
Sepsis |
| Colitoxicosis |
Sepsis |
| Collagen punctal plug |
Collagen punctal plug (physical object) |
| kollagenaspreparat |
Collagenase |
| Collection of 24-hour urine specimen for laboratory |
Urine specimen collection, 24 hours |
| Collection of specimen by nursing |
Specimen collection |
| pigmentrubbning hos kolgruvearbetare |
Collier's stripes (finding) |
| kolobom i regnbågshinna |
Congenital coloboma of iris |
| Colonic gland |
Colonic crypt of Lieberkühn |
| Colonnas osteotomi av medfödd höftdeformitet |
Colonna arthroplasty (procedure) |
| Colonoscopy equivocal |
Colonoscopy equivocal (finding) |
| kolonibildande enhet |
Stem cell colony-forming unit |
| kolonibildande enhet: basofil |
Colony-forming unit of basophilic lineage (cell) |
| kolonibildande enhet: blast |
Blast colony-forming unit (cell) |
| kolonibildande enhet: diffusionskammare |
Diffusion chamber colony-forming unit (cell) |
| kolonibildande enhet: eosinofil |
Colony-forming unit of eosinophilic lineage (cell) |
| kolonibildande enhet: erytroid |
Colony-forming unit of erythroid lineage (cell) |
FHIR